Bulletin
Investor Alert

Market Pulse Archives

Sept. 24, 2020, 1:46 p.m. EDT

PMV Pharma upsizes IPO by 60%, to now raise up to $211.8 million

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    PMV Pharmaceuticals Inc. (PMVP)
  • X
    Renaissance IPO ETF (IPO)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

PMV Pharmaceuticals Inc. /zigman2/quotes/221335100/composite PMVP +1.73% has upsized its initial public offering by 60%, as the oncology company now looks to raise up to $211.8 million. The company is now offering 11.765 million shares in the IPO, up from 7.350 million, while the IPO's expected pricing range remains at between $16 and $18 a share. If the underwriters of the offering exercise options to buy up to an additional 1.76 million shares to cover overallotments, the company could raise up to $243.5 million. The company is looking to go public at a time that the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO +1.46% has rallied 60.7% year to date, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.30% has gained 1.4%.

/zigman2/quotes/221335100/composite
US : U.S.: Nasdaq
$ 35.34
+0.60 +1.73%
Volume: 127,189
Oct. 27, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.49 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/207665280/composite
US : U.S.: NYSE Arca
$ 54.09
+0.78 +1.46%
Volume: 145,567
Oct. 27, 2020 4:00p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,390.68
-10.29 -0.30%
Volume: 2.38B
Oct. 27, 2020 5:20p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.